An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
CareDx (Nasdaq: CDNA), a company focused on innovative healthcare solutions for transplant patients, has announced its plan to release second quarter 2024 financial results on Wednesday, July 31, 2024, after the market closes. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results. Interested parties can join the call by dialing 1-800-267-6316 (domestic) or 1-203-518-9783 (international) and using the Conference ID: CareDx. Additionally, a live webcast will be available on the investor relations section of CareDx's website.
Positive
None.
Negative
None.
BRISBANE, Calif.--(BUSINESS WIRE)--
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the second quarter 2024 after market close on Wednesday, July 31, 2024. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers. Please reference Conference ID: CareDx. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
When will CareDx (CDNA) report its Q2 2024 financial results?
CareDx (CDNA) will report its second quarter 2024 financial results after market close on Wednesday, July 31, 2024.
How can investors join CareDx's (CDNA) Q2 2024 earnings call?
Investors can join CareDx's Q2 2024 earnings call by dialing 1-800-267-6316 for domestic callers or 1-203-518-9783 for international callers, using the Conference ID: CareDx. A live webcast will also be available on the company's investor relations website.
What time is CareDx's (CDNA) Q2 2024 earnings conference call?
CareDx's Q2 2024 earnings conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Wednesday, July 31, 2024.
Where can I find CareDx's (CDNA) Q2 2024 earnings webcast?
CareDx's Q2 2024 earnings webcast can be accessed through the investor relations section of the company's website at investors.caredxinc.com.
